A team of Canadian researchers at McMaster University is developing an inhalable TB vaccine that would act as a booster to strengthen immune protection right at the site of infection — the lungs. If successful, it would be among the first new effective TB vaccines in the world.
Topic: public health
The COVID-19 pandemic’s short- and long-term impacts on Canadian innovation will be “mixed,” with new opportunities but also negative consequences, academic experts told a webinar presented by the Munk School of Global Affairs and Public Policy.
Canada’s chief science advisor Dr. (PhD) Mona Nemer says she’d be “pleased” to provide input into a new long-term research and pandemic preparedness strategy being developed by the federal government. Nemer also co-chairs a group providing advice on health data needed to manage disease spread, an area public health experts say needs significant improvement.
The federal government is developing Canada’s first long-term research and pandemic preparedness strategy that will include a new Centre for Pandemic Preparedness and Health Emergencies Research. Ottawa has provided nearly $1 million to the Canadian Institutes of Health Research to lead its development.
New challenges in public health were recently announced under the Innovative Solutions Canada program, which aims to help small and mid-sized enterprises sell their innovative products and services to the government. Public Health Agency of Canada is looking for solutions for satellite images and communications platforms. The National Research Council of Canada needs suppliers for…